research and development
Dr Mikael von Euler moves to Oncos Therapeutics
February 10, 2011Research and Development Dr Mikael von Euler, Oncos Therapeutics, appointment, research and development
Finnish biotech company Oncos Therapeutics has appointed Dr Mikael von Euler as chief medical officer. He has more than 20 …
Shire bags senior research execs from GSK and Abbott
February 9, 2011Research and Development Dr Lawson Macartney, Dr Mario Saltarelli, Shire, appointment, recruitment, research and development
Shire has strengthened its speciality pharmaceuticals business with the appointment of senior research executives from GlaxoSmithKline and Abbott. Dr Lawson …
Dr Matthias joins Noxxon Pharma
February 9, 2011Research and Development Dr Matthias Baumann, Noxxon Pharma, appointment, research and development
Berlin-based biotech Noxxon Pharma has appointed Dr Matthias Baumann as chief medical officers. He joins from Focus Clinical Drug Development, …
Bertil Lindmark joins Almirall as R&D head
January 27, 2011Research and Development Almirall, Bertil Lindmark, appointment, research and development
Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …
Lilly Oncology chief resigns
January 27, 2011Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing
Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …
Dr Marie-Paule Richard joins AiCuris as CMO
January 26, 2011Research and Development AiCuris, Dr Marie-Paule Richard, appointment, research and development
German clinical research company AiCuris has appointed Dr Marie-Paule Richard as chief medical officer. She has over 24 years of …
Penn Pharma appoints Wyeth’s Edward Rowland
January 20, 2011Manufacturing and Production, Research and Development Edward Rowland, Penn Pharma, appointment, manufacturing and production, research and development
Edward Rowland has joined Wales-based pharmaceutical drug developer and manufacturer Penn Pharma as head of operational analytical services. He moves …
EMA’s Thomas Lönngren joins market access firm
January 19, 2011Research and Development, Sales and Marketing NDA Group, Thomas Lönngren, appointment, recruitment, research and development, sales and marketing
The former head of the EMA Thomas Lönngren has taken up a post at new European regulatory and market access …
Syntaxin appoints Russell Greig chairman
January 19, 2011Research and Development Russell Greig, appointment, research and development, syntaxin
Oxford, UK-based biotechnology company Syntaxin has appointed Dr Russell Greig as its new chairman.Russell has over 30 years experience in …
Dr Simon Thorn joins Spectrum Regulatory Solutions
January 12, 2011Research and Development Dr Simon Thorn, Specrum Regulatory Services, appointment, research and development
Spectrum Regulatory Solutions has appointed Dr Simon Thorn as a senior regulatory writer. He has more than 15 years experience …
Biogen Idec appoints new head of R&D
January 6, 2011Research and Development, Sales and Marketing Biogen IDEC, Douglas Williams, Steven Holtzman, appointment, research and development, sales and marketing
Biogen Idec has a new head of research and development, appointing Douglas Williams to oversee its global operations. The position …
GSK’s Dr Anne Phillips moves to Novo Nordisk
January 4, 2011Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing
Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …
Merck KGaA appoints new head of pharma
December 17, 2010Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing
Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …
Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D
December 15, 2010Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development
Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
Elan names Robert Ingram as new chairman
December 10, 2010Research and Development, Sales and Marketing Elan, appointment, research and development, sales and marketing
Elan has appointed former Glaxo Wellcome chief executive Robert Ingram as its chairman-designate. Ingram led Glaxo between 1997 and 2000 …
